Home

Prevention

Read time: 3 min

Congress highlights

Real world evidence or clinical trials – what informs clinical practice the most?

In a scientific session at the 16th European Headache Congress, Vienna, Austria, the expert faculty...

Alzheimer's Disease

Read time: 3 min

Congress highlights

New perspectives on Alzheimer’s disease

Alzheimer’s disease is not part of normal aging. It is a brain disorder and not all people...

Read time: 3 min

Satellite symposium

Acute and preventive migraine therapies: an evolving therapeutic landscape

Failure to respond to at least some of the many acute and preventive treatments for migraine is not...

Read time: 3 min

Satellite symposium

Raising the bar for successful migraine prevention

A 75% reduction in migraine days can be achieved in up to one-third of patients with chronic...

Read time: 3 min

Satellite symposium

New real-world data on the use of calcitonin gene-related peptide monoclonal antibodies for migraine prevention

New real-world data on the effectiveness, tolerability, and other benefits of migraine prevention...

Read time: 3 min

Satellite symposium

Getting a head start on Migraine Prevention

Migraine prevention is important to patients and clinicians. A recent Consensus Statement on...

Read time: 3 min

Congress highlights

Understanding the relationship between depression and heart disease to improve patient care

Major depressive disorder (MDD) is associated with an increased risk of cardiovascular disease (CVD...

Read time: 4 min

Satellite symposium

Experts’ perspectives on managing chronic migraine in their own clinical practice

Three experts from different countries provided perspectives on their own clinical practice...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind Greece Continue to Progress in Mind South East Asia Continue to Progress in Mind Middle East & Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Japan RC Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Sweden Continue to Progress in Mind Finland Continue to Progress in Mind Ukraine Continue to Progress in Mind Belgium & Luxembourg Continue to Progress in Mind Switzerland Continue to Progress in Mind Germany Continue to Progress in Mind Austria

You are leaving Progress in Mind

Continue to

Cancel

Progress in Mind Netherlands

Accept Cancel

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intended for health care professionals.

All the information included in the Website is related to diseases, investigations and existing or potential treatment options and, therefore, directed to health professionals . The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country